List view / Grid view
Elan Corporation announces a series of transactions designed to decisively…
20 May 2013 | By Elan Corporation
Elan Corporation announces a series of transactions designed to decisively transform and advance the company...
The U.S. FDA has approved a product label change for…
20 January 2012 | By Biogen Idec and Elan Corporation, plc
The U.S. FDA has approved a product label change for TYSABRI...
€3m grant to combine business & science disciplines at University…
12 December 2011 | By Elan Corporation, plc
€3m grant to combine business & science disciplines at University College Dublin...
Alkermes will merge with EDT in a cash and stock…
9 May 2011 | By Elan Drug Technologies (EDT)
Alkermes will merge with EDT in a cash and stock transaction currently valued at approximately $960 million...
